Jane Ryan
Director/Board Member bei BIONOMICS LIMITED
Profil
Jane Ryan is currently an Independent Non-Executive Director at Idt Australia Ltd., Bionomics Ltd., and Robotic Surgery Evolution Ltd.
She is also a Director at Diabetes Victoria and a Member of the Australian Institute of Co. Directors.
In the past, she served as the Chief Executive Officer at Sementis Ltd.
and as a Vice President-Product Development at Biota Holdings Pty Ltd.
and Bio Innovation SA. She was also a Non-Executive Director at Anatara Lifesciences Ltd.
from 2018 to 2023.
Additionally, she held various director positions at Diabetes Australia-VIC, Diabetes Vaccine Development Centre Ltd., Veski, and Reef Pharmaceuticals Pty Ltd.
Dr. Ryan received her undergraduate degree from the Australian National University and her doctorate from Macquarie University.
Aktive Positionen von Jane Ryan
| Unternehmen | Position | Beginn |
|---|---|---|
| BIONOMICS LIMITED | Director/Board Member | 01.10.2020 |
| IDT AUSTRALIA LIMITED | Director/Board Member | 28.01.2022 |
Australian Institute of Co. Directors
 Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Australian Institute of Co. Directors is a non-profit organization that provides leadership on director issues. It offers governance education, director development, and advocacy. The organization was founded in January 1, 1990 and is headquartered in Sydney, Australia. | Corporate Officer/Principal | - |
| Robotic Surgery Evolution Ltd. | Director/Board Member | 01.11.2021 |
| Diabetes Victoria | Director/Board Member | - |
Ehemalige bekannte Positionen von Jane Ryan
| Unternehmen | Position | Ende |
|---|---|---|
| ANATARA LIFESCIENCES LTD | Director/Board Member | 02.10.2023 |
Sementis Ltd.
 Sementis Ltd. BiotechnologyHealth Technology Sementis Ltd. is an Australian private company that develops next-generation vaccine viral-vector software platform. | Chief Executive Officer | 01.01.2017 |
| Diabetes Vaccine Development Centre Ltd. | Director/Board Member | - |
| Veski | Director/Board Member | - |
| ░░░░ ░░░░░░░░░░░░░░░ ░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | - |
Ausbildung von Jane Ryan
| Australian National University | Undergraduate Degree |
| Macquarie University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| IDT AUSTRALIA LIMITED | Health Technology |
| BIONOMICS LIMITED | Health Technology |
| ANATARA LIFESCIENCES LTD | Health Technology |
| Private Unternehmen | 11 |
|---|---|
Biota Holdings Pty Ltd.
 Biota Holdings Pty Ltd. Pharmaceuticals: MajorHealth Technology Biota Holdings Pty Ltd. operates as an anti infective drug development firm. The company was founded on October 2, 1985 and is headquartered in Notting Hil, Australia. | Health Technology |
Australian Institute of Co. Directors
Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Australian Institute of Co. Directors is a non-profit organization that provides leadership on director issues. It offers governance education, director development, and advocacy. The organization was founded in January 1, 1990 and is headquartered in Sydney, Australia. | Commercial Services |
| Diabetes Australia-VIC | |
| Diabetes Vaccine Development Centre Ltd. | |
Aviragen Therapeutics, Inc.
 Aviragen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aviragen Therapeutics, Inc. engages in the discovery and development of direct-acting antivirals to treat infections. Its product candidates include vapendavir, an oral treatment for human rhinovirus infections in moderate-to-severe asthmatics; BTA074, a topical antiviral treatment for genital warts caused by human papillomavirus types 6 & 11; BTA585, an oral fusion protein inhibitor for the treatment of RSV-A and RSV-B infections; and laninamivir octanoate, a one-time, inhaled treatment for influenza A and B infections. The company was founded on November 8, 2012 and is headquartered in Alpharetta, GA. | Health Technology |
| Veski | |
Sementis Ltd.
Sementis Ltd. BiotechnologyHealth Technology Sementis Ltd. is an Australian private company that develops next-generation vaccine viral-vector software platform. | Health Technology |
| Reef Pharmaceuticals Pty Ltd. | |
| Diabetes Victoria | |
| Robotic Surgery Evolution Ltd. | |
Bio Innovation SA
 Bio Innovation SA Miscellaneous Commercial ServicesCommercial Services Bio Innovation SA promotes biotechnology development projects. It offers start-ups and early stage customized programs including grants, business and marketing assistance, lab and office space and access to global networks. The company was founded in 2001 and is headquartered in Thebarton, Australia. | Commercial Services |
